Krung Thep, Thailand In 2017 was created K2 Venture Capital, which is appeared as VC. The main department of described VC is located in the Bangkok. The venture was found in Asia in Thailand.
The fund has exact preference in some founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Indonesia. Among the most popular fund investment industries, there are E-Commerce Platforms, Developer Platform. Among the most popular portfolio startups of the fund, we may highlight UangTeman, UangTeman, Plum. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the K2 Venture Capital, startups are often financed by Alpha JWC Ventures, STI Financial Group, Qiming Venture Partners. The meaningful sponsors for the fund in investment in the same round are STI Financial Group, Draper Associates, Alpha JWC Ventures. In the next rounds fund is usually obtained by Draper Associates, Asia Summit Capital, STI Financial Group.
Considering the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2017. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The overall number of key employees were 2.
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
LTZ Therapeutics | $20M | 30 Jul 2024 | San Francisco, California, United States | ||
LTZ Therapeutics | $10M | 31 May 2023 | San Francisco, California, United States | ||
Sironax | $200M | 02 Aug 2022 | Dongcheng District, Beijing, China | ||
Plum | $20M | 23 Sep 2019 | Beijing, Beijing, China | ||
UangTeman | $12M | 07 Aug 2017 | Jakarta, Jakarta Raya, Indonesia | ||
Money Table | $1M | 21 Feb 2017 | Thailand, Bangkok |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
LTZ Therapeutics | $20M | 30 Jul 2024 | San Francisco, California, United States | ||
LTZ Therapeutics | $10M | 31 May 2023 | San Francisco, California, United States | ||
Sironax | $200M | 02 Aug 2022 | Dongcheng District, Beijing, China | ||
Plum | $20M | 23 Sep 2019 | Beijing, Beijing, China | ||
UangTeman | $12M | 07 Aug 2017 | Jakarta, Jakarta Raya, Indonesia | ||
Money Table | $1M | 21 Feb 2017 | Thailand, Bangkok |
